These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8256793)

  • 21. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fracture incidence in 803 women with postmenopausal osteoporosis under drug treatment].
    Cronenberg A; Minkus A; Bremer G; Keck E
    Z Orthop Ihre Grenzgeb; 1993; 131(1):70-4. PubMed ID: 8480444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of osteoporosis is still a valid aim for hormone therapy.
    Sturdee DW; Maclennan AH
    Climacteric; 2005 Jun; 8(2):97-8. PubMed ID: 16096165
    [No Abstract]   [Full Text] [Related]  

  • 24. [The Medical Products Agency on prevention of osteoporosis: estrogen reduces the risk of fractures in certain women].
    Lakartidningen; 1994 Jan; 91(1-2):58-60. PubMed ID: 8289556
    [No Abstract]   [Full Text] [Related]  

  • 25. [Estrogens for treatment of osteoporoses].
    Higuchi T; Tarakida A; Abe K; Mizunuma H
    Nihon Rinsho; 2009 May; 67(5):954-9. PubMed ID: 19432116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.
    Komm BS; Morgenstern D; A Yamamoto L; Jenkins SN
    Expert Rev Clin Pharmacol; 2015; 8(6):769-84. PubMed ID: 26482902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.
    Roux C
    Rev Rhum Engl Ed; 1997 Jun; 64(6):402-9. PubMed ID: 9513613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 29. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis. Current pharmacologic options for prevention and treatment.
    Isenbarger DW; Chapin BL
    Postgrad Med; 1997 Jan; 101(1):129-32, 136-7, 141-2. PubMed ID: 9008693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current approaches to the prevention and treatment of postmenopausal osteoporosis.
    Follin SL; Hansen LB
    Am J Health Syst Pharm; 2003 May; 60(9):883-901; quiz 903-4. PubMed ID: 12756940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The waning effect of postmenopausal estrogen therapy on osteoporosis.
    Ettinger B; Grady D
    N Engl J Med; 1993 Oct; 329(16):1192-3. PubMed ID: 8377785
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005.
    Islam S; Liu Q; Chines A; Helzner E
    Menopause; 2009; 16(1):77-83. PubMed ID: 18703983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating therapeutic modalities for prevention and treatment of postmenopausal osteoporosis.
    Sagraves R
    Ann Pharmacother; 2003 May; 37(5):744-6. PubMed ID: 12708956
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone replacement therapy in the prevention of osteoporosis. Evolution of therapeutic methods].
    Trémollières F; Ribot C
    Presse Med; 1999 Jun; 28(22):1188-94. PubMed ID: 10414248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture.
    McGarry KA; Kiel DP
    Postgrad Med; 2000 Sep; 108(3):79-82, 85-8, 91. PubMed ID: 11004937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.